Tenderwize
Back to tender search

Open house drug discount agreements Tiotropiumbromide, inhalation solution (Respimat(R)), ATC R03BB04

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Sep 03, 2027 · 382 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tiotropiumbromid, in der Darreichungsform Inhalationslösung (Respimat(R)), ATC R03BB04

60/100

Opportunity Score

PromisingLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

60 / 100

Complexity

30 / 100

Risk factors

Automatic termination of the open house agreement if a nationwide or state-level discount contract for the same active...

Strict submission rules: paper copies must be received by the 10th of the month if a scan is sent earlier; electronic s...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Oct 2027
  • Non-exclusive discount agreements for Tiotropiumbromide inhalation solution (Respimat(R)), ATC R03BB04.
  • Contract duration from 01.11.2025 to 31.10.2027.
Show full summary

Open house model for non-exclusive discount agreements with pharmaceutical companies for Tiotropiumbromide inhalation solution. No selection procedure; all eligible companies can join. Contract period 01.11.2025-31.10.2027, with possible earlier termination if a regular discount contract comes into effect. Submission: signed documents in paper or with qualified electronic signature. Only pharmaceutical companies eligible.

Risks

Automatic termination of the open house agreement if a nationwide or state-level discount contract for the same active...

Strict submission rules: paper copies must be received by the 10th of the month if a scan is sent earlier; electronic s...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible.

Administrative

  • Submission of signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed declaration of reliability.
  • Documents must be submitted either in paper (2 copies, signed by hand) or electronically with a qualified electronic signature.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria; contracts are offered to all eligible participants.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house drug discount agreements Tiotropiumbromide, inhalation solution (Respimat(R)), ATC R03BB04

Non-exclusive discount agreement for the active ingredient Tiotropiumbromide in inhalation solution (Respimat). All eligible pharmaceutical companies can join. Contract duration 01.11.2025-31.10.2027. Submission of signed contract and declaration of reliability required.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Oct 2025 - Oct 2027

Category

Pharmaceutical products

Award Criteria

No award criteria; contracts are offered to all eligible participants.

Deadline

Deadline Sep 03, 2027

Procurement Details

Publication date
14 Sep 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
599784-2025

Documents (2)

Similar tenders